TOFACITINIB FOR THE TREATMENT OF ULCERATIVE COLITIS: UP TO 6.8 YEARS OF SAFETY DATA FROM GLOBAL CLINICAL TRIALS

William Sandborn  ¹     Julian Panés  ²     Geert D’Haens  ³     Bruce E. Sands  ⁴     Remo Panaccione  ⁵     Siew Cheng Ng  ⁶     Thomas V Jones     Nervin Lawendy     nicole kulisek     Rajiv Mundayat     Chinyu Su    
¹ University of California San Diego,La Jolla,United States
² Hospital Clínic de Barcelona, IDIBAPS, CIBERehd,Barcelona,Spain
³ Academic Medical Center,Amsterdam,Netherlands
⁴ Icahn School of Medicine at Mount Sinai,New York,United States
⁵ University of Calgary,Calgary,Canada
⁶ Center for Gut Microbiota Research, Department of Medicine and

Session
IBD (Posters)

Conference
UEG Week Virtual 2020

Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)